COGNOA
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral health conditions, such as autism. Its ai technology platform will enable the product pipeline to address additional unmet needs including adhd and anxiety. It is focused on improving the lives and outcomes of children and families living with behavioral conditions.
COGNOA
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2013-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.cognoa.com
Total Employee:
51+
Status:
Active
Total Funding:
53.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Board_member
2020-01-01
Current Employees Featured
Sharief Taraman, M.D. Chief Medical Officer @ Cognoa
Chief Medical Officer
Dennis Wall Founder @ Cognoa
Founder
2013-09-01
Dave Happel President & CEO @ Cognoa
President & CEO
2020-03-01
Halim Abbas Chief AI Officer @ Cognoa
Chief AI Officer
Eric Mosbrooker Chief Operating Officer @ Cognoa
Chief Operating Officer
2020-01-01
Anthony M. Rimac Chief Financial Officer @ Cognoa
Chief Financial Officer
2021-09-01
Founder
Investors List
Stanford Technology Ventures Program
Stanford Technology Ventures Program investment in Series A - Cognoa
Morningside Venture Investments
Morningside Venture Investments investment in Series A - Cognoa
Morningside Group
Morningside Group investment in Series A - Cognoa
Morningside Group
Morningside Group investment in Series A - Cognoa
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-30 | Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer |
Official Site Inspections
http://www.cognoa.com
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cognoa"
About Us - Cognoa
Cognoa is an early childhood development and pediatric behavioral health company. We develop digital diagnostics and therapeutics that enable earlier and more equitable access to care to improve the lives and outcomes of children …See details»
Cognoa - Crunchbase Company Profile & Funding
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral …See details»
Cognoa Company Profile | Management and Employees List
Cognoa Profile and History. Cognoa is a pediatric behavioral health company developing digital diagnostic and therapeutic products with the goals of enabling earlier and more equitable …See details»
Cognoa - LinkedIn
Cognoa | 4,581 followers on LinkedIn. Digital diagnostics & therapeutics to enable earlier & more equitable treatment of behavioral health conditions. | Cognoa is a pediatric …See details»
Contact - Cognoa
Cognoa is an early childhood development and pediatric behavioral health company developing digital diagnostics and therapeutics to enable earlier and more equitable access to care that improves the lives and outcomes of …See details»
Cognoa - Funding, Financials, Valuation & Investors - Crunchbase
Cognoa is funded by 3 investors. Morningside and Stanford Technology Ventures Program are the most recent investors. Cognoa has a post-money valuation in the range of $10M to $50M …See details»
Cognoa Company Overview, Contact Details & Competitors | LeadIQ
Nov 14, 2022 Cognoa. Hospitals and Health Care California, United States 51-200 Employees. Cognoa innovates solutions for child developmental health. We build breakthrough products …See details»
Cognoa Company Profile - Office Locations, Competitors, Revenue …
Cognoa has 5 employees at their 1 location and $11.6 m in total funding,. See insights on Cognoa including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Cognoa: Pioneering AI for Autism Diagnosis and Its Implications
Sep 5, 2024 Founded in 2014, Cognoa has been on a mission to facilitate earlier autism diagnoses through data-driven methods. The road was long and riddled with challenges, from …See details»
Cognoa’s autism devices win breakthrough status - MedTech Dive
Feb 6, 2019 Cognoa was founded by Dennis Wall, an associate professor at Stanford University whose research has sought to improve the diagnosis and treatment of ASD through the use of …See details»
Shining a spotlight on children’s health with Cognoa
Jan 22, 2024 He is recognized as one of the world's top autism researchers, has more than 200 papers and patents published to his name and is the founder of Cognoa, a company …See details»
Cognoa’s AI-based autism diagnosis aid gets FDA de novo clearance
Jun 3, 2021 The US Food and Drug Administration (FDA) has granted de novo clearance to market Cognoa’s artificial intelligence (AI)-based autism diagnosis aid, Canvas Dx. Canvas Dx …See details»
Technology - Cognoa
At Cognoa, we use responsible AI and a whole child data approach to better understand, track and treat children with behavioral health conditions. Smart, accessible, equitable diagnostics …See details»
Sign In - Cognoa
Support your employees with their number one concern: their children.See details»
Cognoa teams up with Autism Learning Partners to distribute its ...
Feb 11, 2020 Cognoa’s app includes activities designed to support the growth of motor, social and emotional skills, and also help clinicians assess and identify children at risk for autism …See details»
Cognoa's CEO shuffle, Liva Healthcare's new CCO and more digital …
Mar 24, 2020 Digital pediatric-behavioral-health company Cognoa announced today the appointment of David Happel as its new CEO. He comes from biopharmaceutical company …See details»
Cognoa Demonstrates Advances of its AI-Based Technology for
Aug 27, 2018 Cognoa is developing AI-based digital diagnostics and personalized therapeutics that are designed to provide accurate, earlier diagnoses and more effective treatments to …See details»
Cognoa Selected as Finalist in Fierce Innovation Awards – …
Dec 5, 2019 Cognoa was recognized as a finalist in the category of Technology Innovation. Cognoa is developing what is expected to be the first diagnostic for autism spectrum disorder …See details»
Cognoa unveils Highmark as first commercial payer partner
Jan 26, 2024 Cognoa, maker of the first FDA-approved autism diagnostic tool, announced Highmark has signed on as its first commercial payer partner. The tool, Canvas Dx, will now …See details»
How COOs maximize operational impact from gen AI and agentic AI
3 days ago Second, they can shape the organization’s data governance, addressing the complex challenges associated with extracting and structuring data from legacy operating …See details»